Pharmaceutical company
general healthcare issues related to pharmaceutical and biological products; Federal, Food, Drug and Cosmetic Act (21 USC 9); Public Health Service Act (42 USC 6A); Follow-on Biologics; Comparative Effectiveness; Comparative Effectiveness Research Act (S.3408); Enhanced Health Care Value for All Act (HR2184); Promoting Innovation and Access to Life-saving Medicine Act (HR1427/S.726); Biologics Price Competition and Innovation Act of 2007 (S.1695); Pathway for Biosimilars Acr (HR1548); Health Reform; America's Affordable Health Choices Act (HR3200); America's Healthy Future Act general Medicare and Medicaid issues, including but not limited to, coverage and reimbursement; America's Affordable Health Choices Act (HR3200); America's Healthy Future Act
HCR - Health Issues MMM - Medicare/Medicaid
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
CAPITOL HILL CONSULTING GROUP
926 Pennsylvania Ave, SE, Washington, DC, 20003, US
BILL K BREWSTER STEVEN E IRIZARRY BILL K BREWSTER STEVEN E IRIZARRY